Swedish study finds unacceptably high rate of unwarranted cataract surgery

Swedish study finds unacceptably high rate of unwarranted cataract surgery

A review of the Swedish National Cataract Registry shows that about 4.0 per cent of patients in 2012 and 5.5 per cent in 2013 received cataract surgery without a discernible clinical indication, Mats Lundström MD PhD, Karlskrona, Sweden, reported. Of these, 19 per cent perceived greater visual disability after surgery than before, another 10 per cent reported no improvement and 9 per cent ended up with worse visual acuity after surgery.

The study examined indications for 4,325 first eye and 2,974 second eye procedures performed at 46 surgical units in the month of March. Cases with documented preoperative visual acuity of 20/40 or less, patient dissatisfaction with vision, perceived difficulty performing daily life functions due to vision problems or a surgeon’s reason for surgery, such as anisometropia or high IOP, were excluded. That left 47 first eye surgeries and 142 second eye surgeries without what reviewers considered an adequate clinical indication.

Projecting these numbers onto an entire year, this means about 900 first eye surgeries and 2,500 second eye surgeries were done in Sweden in 2013 with a 30 per cent risk of not perceiving better visual function and a 9 per cent risk of worse visual outcome after surgery, Prof Lundstrom said. “If we go outside of health care and talk about these risk numbers for delivering a service or product, they are definitely, definitely, definitely unacceptable.”

Prof Lundstrom intends to follow the trend for 2014. He also will start a discussion within the ophthalmic community about indications for cataract surgery – before payers do it for the profession.

 

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...